The objective of the Administrative Core is to provide overall guidance, coordination and leadership for the Center. The administrative and scientific leadership of the Center is provided by Dr. N.F. LaRusso, Director, and Drs. G. Farrugia, G.J Gores, and V.H. Shah, Associate Directors, in conjunction with an Executive Committee, an Internal Advisory Committee-, and an External Advisory Committee. The Executive Committee is comprised of the Director, Associate Directors, Core Directors, and the Leaders of the Mechanistic Research Theme groups (Signal Transduction, Membrane Receptors/Ion Channels, and Genetics/Gene Regulation) and meets monthly. The Executive Committee will periodically assess the Research Base striving to enhance membership by committed investigators, especially by attracting additional investigators to pursue digestive disease studies. The Internal Advisory Committee will meet quarterly and will provide regular input to the Executive Committee regarding the strategic direction of the Center and will facilitate communication with institutional leaders to ensure that the Center remains responsive to overall institutional needs. The External Advisory Committee consists of four internationally prominent investigators who are leaders in digestive disease research and will meet annually in person and by conference call as needed to provide regular feedback to the Executive Committee. An Administrator will provide the necessary support for real-time financial management and operations of the Center. The administrative leadership will assure responsiveness of the Center Cores to the needs of the Research Base, and provide oversight for Core functions. In addition, the Administrative Core will support and manage the Scientific Enrichment Program, which is comprised of: i.) a seminar series involving intra- and extra-mural speakers;ii.) research retreats for the Center members and fellows/graduate students;and, iii.) a Mini-Sabbatical Program. Finally, the Administrative Core will coordinate the Pilot and Feasibility Program, which is designed to attract new and seasoned investigators to pursue digestive disease research. This Administrative Core is already functional as illustrated by the coordinated efforts required to develop and submit this proposal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK084567-03
Application #
8309300
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
3
Fiscal Year
2011
Total Cost
$412,791
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Bandla, Harikrishna; Dasgupta, Debanjali; Mauer, Amy S et al. (2018) Deletion of endoplasmic reticulum stress-responsive co-chaperone p58IPK protects mice from diet-induced steatohepatitis. Hepatol Res 48:479-494
Guicciardi, Maria Eugenia; Trussoni, Christy E; Krishnan, Anuradha et al. (2018) Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol 69:676-686
Mouchli, Mohamad A; Singh, Siddharth; Boardman, Lisa et al. (2018) Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflamm Bowel Dis 24:1074-1081
Paradise, Brooke D; Barham, Whitney; Fernandez-Zapico, Martín E (2018) Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes? Cancers (Basel) 10:
Banales, Jesus M; Marzioni, Marco; LaRusso, Nicholas F et al. (2018) Cholangiocytes in health and disease: From basic science to novel treatments. Biochim Biophys Acta Mol Basis Dis 1864:1217-1219
Tarragó, Mariana G; Chini, Claudia C S; Kanamori, Karina S et al. (2018) A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline. Cell Metab 27:1081-1095.e10
Kim, Minsoo; Druliner, Brooke R; Vasmatzis, Nikolaos et al. (2018) Inferring modes of evolution from colorectal cancer with residual polyp of origin. Oncotarget 9:6780-6792
Druliner, Brooke R; Wang, Panwen; Bae, Taejeong et al. (2018) Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations. Sci Rep 8:3161
Mansini, Adrian P; Lorenzo Pisarello, Maria J; Thelen, Kristen M et al. (2018) MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma. Hepatology 68:561-573
Moncsek, Anja; Al-Suraih, Mohammed S; Trussoni, Christy E et al. (2018) Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. Hepatology 67:247-259

Showing the most recent 10 out of 537 publications